S100A9 _ Calgranulin_B _ MRP14
- Known as:
- S100A9 _ Calgranulin_B _ MRP14
- Catalog number:
- MC479
- Product Quantity:
- 0.1 mg
- Category:
- -
- Supplier:
- ACR
- Gene target:
- S100A9 _ Calgranulin_B MRP14
Related genes to: S100A9 _ Calgranulin_B _ MRP14
- Gene:
- S100A9 NIH gene
- Name:
- S100 calcium binding protein A9
- Previous symbol:
- CAGB, CFAG
- Synonyms:
- P14, MIF, NIF, LIAG, MRP14, MAC387, 60B8AG, CGLB
- Chromosome:
- 1q21.3
- Locus Type:
- gene with protein product
- Date approved:
- 1989-05-19
- Date modifiied:
- 2018-05-02
Related products to: S100A9 _ Calgranulin_B _ MRP14
Related articles to: S100A9 _ Calgranulin_B _ MRP14
- Autism spectrum disorder (ASD) is a complex neurodevelopmental condition often accompanied by gastrointestinal (GI) symptoms. Inflammatory proteins in stool have been proposed as potential biomarkers, but evidence remains inconsistent. We compared fecal levels of α1-antitrypsin (A1AT), immunoglobulin A (IgA), and calprotectin (Cal) in 57 children with ASD and 57 biological siblings without ASD. Sibling designs are now preferred to disentangle ASD-specific biology from shared environmental and microbiome factors. Participants were carefully screened to exclude recent antibiotic use, digestive problems, gastrointestinal infections, and abnormal dietary patterns, thereby controlling for major factors known to influence gut inflammatory markers. - Source: PubMed
Publication date: 2026/04/15
Osredkar JoškoFinderle PetraGodnov UrošJekovec-Vrhovšek MajaVidova VeronikaElliott James PriceFabjan TejaAvguštin GorazdOsredkar DamjanKumer Kristina - Psoriasis and metabolic dysfunction-associated fatty liver disease (MAFLD) share pathological features such as chronic inflammation, immune dysregulation, and metabolic disturbance. Increasing evidence suggests biological crosstalk between the two conditions, offering new insights into their shared mechanisms and comanagement. Early-stage MAFLD, characterized by hepatic steatosis without evident inflammation or fibrosis, provides a crucial window for intervention. This study aimed to identify early diagnostic biomarkers linking psoriasis and MAFLD. - Source: PubMed
Publication date: 2026/04/15
Wang ShanshanChen YanfangYang TingtingZhang DamingLiu YadiZhang ShenglanYang ZishanWei TuanjieQiu LizhenHuang FangXiao Zhiqiang - The cellular heterogeneity and molecular complexity of pulmonary arterial hypertension (PAH) have not been fully elucidated. - Source: PubMed
Publication date: 2026/04/15
Yang YuanqiLei YangWu BojiNing KeShen YangWang XuhongHe JingyuZhang JihangLiu ChuanQin Zhexue - To observe the therapeutic effect of Zaozhu Yinchen Decoction (ZZYC) on rats with non-alcoholic steatohepatitis (NASH) and explore its mechanism of action related to myeloid-derived suppressor cells (MDSCs). - Source: PubMed
Publication date: 2026/04/24
Zhang WenyangWang YujieLiu YaoyuZheng XiaotingWang TianxiangKwan XinyiLiu RuobingLiu QiZhuang HongliLiang HuiqingChen Shaodong - The global prevalence of type 2 diabetes is increasing, significantly affecting individuals' quality of life. While traditional symptomatic treatments have demonstrated some therapeutic benefits, their efficacy remains limited. This study aims to evaluate the relationship between S100A9 protein levels and diabetic retinopathy in patients with type 2 diabetes through a meta- analysis. - Source: PubMed
Publication date: 2026/04/20
Jin JiJi FangfangZhang Ji